Prelude Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.7k | 819 | 2.07 |
| 2024-06-30 | $3.1k | 819 | 3.81 |
| 2024-03-31 | $3.9k | 819 | 4.74 |
| 2023-12-31 | $3.5k | 819 | 4.27 |
| 2023-09-30 | $2.5k | 819 | 3.09 |
| 2023-06-30 | $3.7k | 819 | 4.50 |
| 2022-03-31 | $5.0k | 769 | 6.50 |
| 2021-12-31 | $10k | 769 | 13.00 |
| 2021-09-30 | $24k | 769 | 31.21 |
| 2021-06-30 | $22k | 769 | 28.61 |
| 2021-03-31 | $33k | 769 | 42.91 |
| 2020-12-31 | $55k | 769 | 71.52 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors